BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9004378)

  • 1. Robustness considerations in Bayesian analysis.
    Gustafson P
    Stat Methods Med Res; 1996 Dec; 5(4):357-73. PubMed ID: 9004378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian robustness in meta-analysis for studies with zero responses.
    Vázquez FJ; Moreno E; Negrín MA; Martel M
    Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of direct and indirect evidence in mixed treatment comparisons.
    Lu G; Ades AE
    Stat Med; 2004 Oct; 23(20):3105-24. PubMed ID: 15449338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian inference for agreement measures.
    Vidal I; de Castro M
    J Biopharm Stat; 2017; 27(5):809-823. PubMed ID: 27562901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data.
    Fotouhi AR
    Contemp Clin Trials; 2008 Jul; 29(4):547-54. PubMed ID: 18308644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal Bayesian inference dipole analysis for MEG neuroimaging data.
    Jun SC; George JS; Paré-Blagoev J; Plis SM; Ranken DM; Schmidt DM; Wood CC
    Neuroimage; 2005 Oct; 28(1):84-98. PubMed ID: 16023866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian Equivalence Testing and Meta-Analysis in Two-Arm Trials with Binary Data.
    Kpekpena C; Muthukumarana S
    Comput Math Methods Med; 2018; 2018():8134132. PubMed ID: 30159005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical Bayesian spatiotemporal analysis of revascularization odds using smoothing splines.
    Silva GL; Dean CB; Niyonsenga T; Vanasse A
    Stat Med; 2008 Jun; 27(13):2381-401. PubMed ID: 17944001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian analysis of proportional hazards models built from monotone functions.
    Gelfand AE; Mallick BK
    Biometrics; 1995 Sep; 51(3):843-52. PubMed ID: 7548703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian partitioning for mapping disease risk using a matched case-control approach to confounding.
    Costain DA
    Biostatistics; 2013 Jan; 14(1):99-112. PubMed ID: 22952389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian analysis for generalized linear models with nonignorably missing covariates.
    Huang L; Chen MH; Ibrahim JG
    Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian approach to DNA sequence segmentation.
    Boys RJ; Henderson DA
    Biometrics; 2004 Sep; 60(3):573-81; discussion 581-8. PubMed ID: 15339274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large hierarchical Bayesian analysis of multivariate survival data.
    Gustafson P
    Biometrics; 1997 Mar; 53(1):230-42. PubMed ID: 9147593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian Latent Class Analysis Tutorial.
    Li Y; Lord-Bessen J; Shiyko M; Loeb R
    Multivariate Behav Res; 2018; 53(3):430-451. PubMed ID: 29424559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.
    Vázquez-Polo FJ; Moreno E; Negrín MA; Martel M
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):317-22. PubMed ID: 25673174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.